0
0

Chapter 38. Treatment of Women

Vivien Burt, M.D., Ph.D.; Rita Suri, M.D.; Carole Edelstein, M.D.
DOI: 10.1176/appi.books.9781585625031.297963

Sections

Excerpt

Although overall men and women are at equal risk for developing a psychiatric disorder over their lifetime, there are gender-specific differences in the prevalence and clinical course of a number of specific mental disorders. These differences stem from a variety of factors, including biological and experiential differences between the sexes. Probably due in part to genetically primed alterations in the risk of depression in response to changing hormones during the menstrual cycle, pregnancy, and the postpartum period, the heritability of major depressive disorder appears to be higher in women than in men (Kendler et al. 2006). These female-specific hormonal and physiological differences predispose women to certain psychiatric illnesses and inform treatment decisions.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Anchor for Jump
Reproductive-related times and events of psychiatric consequence in women
Anchor for Jump
Psychosocial issues of psychiatric consequence in women
Anchor for Jump
Treatment of psychiatric illness in pregnancy
Anchor for Jump
Use of antidepressants in pregnancy: summary points
Anchor for Jump
Commonly used mood stabilizers in pregnancy: summary points
Anchor for Jump
Treatment of pregnant patient with bipolar disorder
Anchor for Jump
Guidelines for management of lithium in pregnant patient with bipolar disorder
Anchor for Jump
Use of antipsychotics in pregnancy: summary points
Anchor for Jump
Postpartum mood disorders
Anchor for Jump
Breast-feeding: issues to consider for postpartum women with psychiatric disorders
Anchor for Jump
Psychotropic medications in breast-feeding: summary points
Anchor for Jump
Summary of eating disorders

References

Alwan S, Reefhuis J, Rasmussen SA, et al: Use of selective serotonin reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684–2692, 2007
[PubMed]
 
American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk. Pediatrics 108:776–789, 2001
[PubMed]
 
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
 
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Arlington, VA, American Psychiatric Association, 2013
 
Anderson EL, Reti IM: ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med 71:235–242, 2009
[PubMed]
 
Baller EB, Wei SM, Kohn PD, et al. Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study. Am J Psychiatry 170:305–314, 2013
[PubMed]
 
Bellace DL, Tesser R, Berthod S, et al: The Yale-Brown-Cornell eating disorders scale self-report questionnaire: a new, efficient tool for clinicians and researchers. Int J Eat Disord 45:856–860, 2012
[PubMed]
 
Bodén R, Lundgren M, Brandt L, et al: Antipsychotics during pregnancy. Arch Gen Psychiatry 69:715–721, 2012
[PubMed]
 
Burt VK, Suri R, Altshuler LL, et al: The use of psychotropic medications during breast-feeding. Am J Psychiatry 158:1001–1009, 2001
[PubMed]
 
Chambers CD, Hernández-Diaz S, Van Martner LJ, et al: Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354:579–587, 2006
[PubMed]
 
Chiu CC, Huang SY, Shen WW, et al: Omega-3 fatty acids for depression in pregnancy (letter). Am J Psychiatry 160:385, 2003
[PubMed]
 
Chung TK, Lau TK, Yip AS, et al: Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 63:830–834, 2001
[PubMed]
 
Cohen LS, Altshuler LL, Harlow BL, et al: Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295:499–507, 2006
[PubMed]
 
Cole JA, Ephross SA, Cosmatos IS, et al. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 16:1075–1085, 2007
[PubMed]
 
Connolly M, Kelly C: Lifestyle and physical health in schizophrenia. Advances in Psychiatric Treatment 11:125–132, 2005
 
Croen LA, Grether JK, Yoshida CK: Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 68:1104–1112, 2011
[PubMed]
 
Dennis CL, Hodnett E, Kenton L, et al: Effect of peer support on prevention of postnatal depression among high risk women: multisite randomized controlled trial. BMJ 15:338:a3064, 2009
[PubMed]
 
Dolk H, Jentink J, Loane M, et al: Does lamo-tri-gine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 71:714–722, 2008
[PubMed]
 
Einarson A, Choi I, Einarson TR, et al: Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 54:242–246, 2009
[PubMed]
 
El Marroun H, Jaddoe VW, Hudziak JJ: Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 69:706–714, 2012
[PubMed]
 
Epperson CN, Steiner M, Hartlage SA, et al: Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 169:465–475, 2012
[PubMed]
 
Evans J, Heron J, Francomb H, et al: Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323:257–260, 2001
[PubMed]
 
Federenko IS, Wadwha PD: Women’s mental health during pregnancy influences fetal and infant developmental and health outcomes. FDA Public Health Advisory. CNS Spectr 9:198–206, 2004
[PubMed]
 
Flynn HA, Blow FC, Marcus SM: Rates and predictors of depression treatment among pregnant women in hospital-affil-iated obstetrics practices. Gen Hosp Psychiatry 28:289–295, 2006
[PubMed]
 
Greene MF: Teratogenicity of SSRIs—serious concern or much ado about little? N Engl J Med 356:2732–2733, 2007
[PubMed]
 
Gutteling BM, de Weerth D, Zandbelt N, et al: Does maternal prenatal stress adversely affect the child’s learning and memory at age six? J Abnorm Child Psychol 34:789–798, 2006
[PubMed]
 
Haas DM, Weida J, Smith R, et al: A comparison of depression symptoms and histories in pregnant women. J Reprod Med 56:39–43, 2011
[PubMed]
 
Harlow BL, Wise LA, Otto MW, et al: Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: The Harvard Study of Moods and Cycles. Arch Gen Psychiatry 60:29–36, 2003
[PubMed]
 
Hill LS, Reid F, Morgan JF, et al: SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord 43:344–351, 2010
[PubMed]
 
Holmes LB, Hernández-Diaz S: Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Def Res A Clin Mol Teratol 94:599–606, 2012
[PubMed]
 
Holmes LB, Wyszynski DF, Baldwin EJ, et al: Increased risk for non-syndromic cleft palate among infants exposed to lamo-tri-gine during pregnancy (abstract). Birth Defects Res A Clin Mol Teratol 76:318, 2006
 
Holmes LB, Mittendorf R, Shen A, et al: Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 68:1275–1281, 2011
[PubMed]
 
Hosseini S, Biglan MW, Larkby C, et al: Trait anxiety in pregnant women predicts offspring birth outcomes. Pediatr Perinat Epidemiol 23:557–566, 2009
[PubMed]
 
Hunter SK, Meondoza JH, D’Anna K, et al: Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating. Am J Psychiatry 169:616–624, 2012
[PubMed]
 
Jablensky AV, Morgan V, Zubrick SR, et al: Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 162:79–91, 2005
[PubMed]
 
Jentink J, Loane MA, Dolk H, et al; EUROCAT Antiepileptic Study Working Group: Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362:2185–2193, 2010
[PubMed]
 
Jimenez-Solem E, Andersen JT, Petersen M, et al: Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2:e001148, 2012
[PubMed]
 
Johnson KC, LaPrairie JL, Brennan PA, et al: Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 69:787–794, 2012
[PubMed]
 
Källén BA, Otterblad Olausson P: Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79:301–308, 2007
[PubMed]
 
Keel PK, Gravener JA, Joiner TE Jr, et al: Twenty-year follow-up of bulimia nervosa and related eating disorders not otherwise specified. Int J Eat Disord 43(6):492–497, 2010
[PubMed]
 
Kelly LE, Poon S, Madadi P, et al: Neonatal benzodiazepine exposure during breastfeeding. J Pediatr 161:448–451, 2012
[PubMed]
 
Kendler KS, Gatz M, Gardner CO, Pedersen NL: A Swedish national twin study of lifetime major depression. Am J Psychiatry 163:109–114, 2006
[PubMed]
 
Khashan AS, Abel KM, McNamee R, et al: Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry 65:146–152, 2008
[PubMed]
 
Kinney DK, Miller AM, Crowley KJ, et al: Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. J Autism Dev Disord 38:481–488, 2008
[PubMed]
 
Kurki T, Hiilesmaa V, Raitasalo R, et al: Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol 95:487–490, 2000
[PubMed]
 
Lewinsohn PM, Striegel-Moore RH, Seeley JR: Epidemiology and natural course of eating disorders in young women from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry 39:1284–1292, 2000
[PubMed]
 
Lin H, Chen I, Chen Y, et al: Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 116:55–60, 2010
[PubMed]
 
Llewellyn AM, Stowe ZN, Nemeroff CB: Depression during pregnancy and the puerperium. J Clin Psychiatry 58 (suppl 15):26–32, 1997
[PubMed]9427874
 
Louik C, Lin AE, Werler MM, et al: First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:2675–2683, 2007
[PubMed]
 
Maguire J, Moody I: GABAAR plasticity during pregnancy: relevance to postpartum depression. Neuron 59:207–213, 2008
[PubMed]
 
Malm H, Artama M, Gissler M, et al: Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol 118:111–120, 2011
[PubMed]
 
Marcus SM, Flynn HA, Blow FC, et al: Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt) 12:373–380, 2003
[PubMed]
 
Matevosyan NR: Pregnancy and postpartum specifics in women with schizophrenia: a meta-study. Arch Gynecol Obstet 283:141–147, 2011
[PubMed]
 
Meador KJ, Baker GA, Browning N, et al: Effects of fetal antiepileptic drug exposure. Neurology 78:1207–1214, 2012
[PubMed]
 
Miller LJ: Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 45:444–450, 1994
[PubMed]
 
Misri S, Reebye P, Kendrick K: Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry 163:1026–1032, 2006
[PubMed]
 
Mulcahy R, Reay RE, Wilkinson RB, et al: A randomized control trial for the effectiveness of group Interpersonal Psychotherapy for postnatal depression. Arch Womens Ment Health 13:125–139, 2010
[PubMed]
 
Munk-Olsen T, Laursen TM, Mendelson T, et al: Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry 66:189–195, 2009
[PubMed]
 
Munk-Olsen T, Laursen TM, Meltzer-Brody S, et al: Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Arch Gen Psychiatry 69:428–434, 2012
[PubMed]
 
Nelson HD, Walker M, Zakher B, et al: Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations. Ann Intern Med 157:104–113, 2012
[PubMed]
 
Newham JJ, Thomas SH, MacRitchie K, et al: Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 192:333–337, 2008
[PubMed]
 
Newport DJ, Calamaras MR, DeVane CL, et al: Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 164:1214–1220, 2007
[PubMed]
 
Nordeng H, van Gelder M, Spigset O: Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 32:186–194, 2012
[PubMed]
 
Nordmo E, Aronsen L, Waasland K, et al: Severe apnea in an infant exposed to lamo-tri-gine in breast milk. Ann Pharmacother 43:1893–1897, 2009
[PubMed]
 
Nulman I, Rovet J, Stewart DE, et al: Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336:258–262, 1997
[PubMed]
 
Nulman I, Rovet J, Stewart DE, et al: Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 159:1889–1895, 2002
[PubMed]
 
O’Hara MW, Swain AM: Rates and risk of postpartum depression—a meta-analysis. International Review of Psychiatry 8:37–54, 1996
 
Papadopoulos FC, Ekbom A, Brandt L, et al: Excess mortality, causes of death and prognostic factors in anorexia nervosa. Br J Psychiatry 194:10–17, 2009
[PubMed]
 
Preti A, Girolamo G, Vilagut G, et al; ESEMeD-WMH Investigators: The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res 43:1125–1132, 2009
[PubMed]
 
Rai D, Lee BK, Dalman C, et al: Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 346:f2059, 2013. Available at: http://www.bmj.com/content/346/bmj.f2059?view=long&pmid=23604083. Accessed August 4, 2013.
[PubMed]
 
Råstam M, Gillberg C, Wentz E: Outcome of teenage-onset anorexia nervosa in a Swedish community-based sample. Eur Child Adolesc Psychiatry 12 (suppl 1):178–190, 2003
[PubMed]
 
Reis M, Källén B: Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 28:279–288, 2008
[PubMed]
 
Rosen DS; American Academy of Pediatrics Committee on Adolescence: Identification and management of eating disorders in children and adolescents. Pediatrics 126:1240–1253, 2010
[PubMed]
 
Ross LE, Grigoriadis S, Mamisashvili L, et al: Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70:436–443, 2013
[PubMed]
 
Rossouw JE, Prentice RL, Manson JE, et al: Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465–1477, 2007
[PubMed]
 
Rubinow DR: Antidepressant treatment during pregnancy: between Scylla and Charybdis (editorial). Am J Psychiatry 163:954–956, 2006
[PubMed]
 
Sharma V, Pope CJ: Pregnancy and bipolar disorder: a systematic review. J Clin Psychiatry 73:1447–1455, 2012
[PubMed]
 
Sharma V, Burt VK, Ritchi HL: Assessment and treatment of bipolar II postpartum depression: a review. J Affect Disord 125:18–26, 2009
[PubMed]
 
Soares CN, Frey BN: Challenges and opportunities to manage depression during the menopausal transition and beyond. Psychiatr Clin North Am 33:296–308, 2010
[PubMed]
 
Sørensen MJ, Grønborg TK, Christensen J, et al: Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol 5:449–459, 2013
[PubMed]
 
Steiner M, Pearlstein T, Cohen LS, et al: Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt) 15:57–69, 2006
[PubMed]
 
Stuenkel CA, Gass MLS, Manson JE, et al: A decade after the Women’s Health Initiative—the experts do agree. Fertil Steril 98:313–314, 2012
[PubMed]
 
Suri R, Altshuler L, Hellemann G, et al: Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 164:1206–1213, 2007
[PubMed]
 
Suri R, Hellemann G, Stowe ZN, et al: A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. J Clin Psychiatry 72:102–107, 2011
[PubMed]
 
Toh S, Hernández-Diaz S, Logan R, et al: Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med 152:211–217, 2010
[PubMed]
 
Touchette E, Henegar A, Godart NT, et al: Subclinical eating disorders and their comorbidity with mood and anxiety disorders in adolescent girls. Psychiatry Res 185:185–192, 2011
[PubMed]
 
U.S.Food and Drug Administration: Selective serotonin reuptake inhibitor (SSRI) antidepressants: drug safety communication—use during pregnancy and potential risk of persistent pulmonary hypertension of the newborn. December 14, 2011. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm283696.htm. Accessed August 2, 2013.
 
Van den Bergh BR, Mulder EJ, Mennes M, et al: Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobehav Rev 29:237–258, 2005
[PubMed]
 
Van den Bergh BR, Van Calster B, Smits T, et al: Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 33:536–545, 2008
[PubMed]
 
van der Lugt MN, van de Maat JS, van Kamp IL, et al: Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies. Early Hum Dev 88:375–378, 2012
[PubMed]
 
Viguera AC, Newport DJ, Ritchie J, et al: Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry 164:342–345, 2007
[PubMed]
 
Viguera AC, Tondo L, Koukopoulos AE, et al: Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 168:1179–1185, 2011
[PubMed]
 
Weikum WM, Oberlander TF, Hensch TK, et al: Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci U S A 109 (suppl 2):17221–17227, 2012
[PubMed]
 
Wichman CL, Moore KM, Lang TR, et al: Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc 84:23–27, 2009
[PubMed]
 
Wilson KL, Zelig CM, Harvey JP, et al: Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors. Am J Perinatol 28:19–24, 2011
[PubMed]
 
Wisner KL, Logsdon MC, Shanahan BR: Web-based education for postpartum depression: conceptual development and impact. Arch Womens Ment Health 11:377–385, 2008
[PubMed]
 
Wisner KL, Sit D KY, Hanusa BH, et al: Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 166:557–566, 2009
[PubMed]
 
Yim IS, Glynn LM, Schechter CD, et al: Risk of postpartum depressive symptoms with elevated corticotrophin-releasing hormone in human pregnancy. Arch Gen Psychiatry 66:162–169, 2009
[PubMed]
 
Yonkers KA, Holthausen GA, Poschman KP, et al: Symptom-onset treatment for women with premenstrual dysphoric disorder. J Clin Psychopharmacol 26:198–202, 2006
[PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 39.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 39.  >
The American Psychiatric Publishing Textbook of Psychiatry, 6th Edition > Chapter 11.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 40.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 64.  >
Topic Collections
Psychiatric News
PubMed Articles
Reproductive depression. Gynecol Endocrinol 2012;28 Suppl 1():42-5.doi:10.3109/09513590.2012.651932.
Premenstrual syndrome and dysphoric disorder as risk factors for postpartum depression. Acta Obstet Gynecol Scand 2013;92(2):178-84.doi:10.1111/aogs.12041.
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation